SCHEMBL30349600

SCHEMBL30349600

Cc1ccc(NC(=O)CC2CN(c3cc(F)c(C4CCC(=O)NC4=O)c(F)c3)C2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 11/20 0.52
▸ DDB1 Q16531 8/20 0.52
▸ GSPT1 P15170 7/20 0.52
▸ MAPT P10636 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ IKZF3 Q9UKT9 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ XBP1 P17861 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26090828 1.00 CRBN (0.52) CRBNDDB1GSPT1MAPTMEN1
SCHEMBL26087906 0.93 CRBN (0.45) CRBNDDB1GSPT1MAPTMEN1
SCHEMBL26087759 0.87 CRBN (0.39) CRBNDDB1GSPT1ALDH1A1LMNA
SCHEMBL30349520 0.87 CRBN (0.39) CRBNDDB1GSPT1ALDH1A1LMNA
SCHEMBL26089566 0.86 LMNA (0.40) CRBNDDB1GSPT1MAPTMEN1
SCHEMBL26086762 0.86 CRBN (0.55) CRBNDDB1GSPT1MEN1KMT2A
SCHEMBL26434916 0.86 CRBN (0.55) CRBNDDB1GSPT1MEN1KMT2A
SCHEMBL26133407 0.85 CRBN (0.52) CRBNDDB1GSPT1MAPTKMT2A
SCHEMBL30349500 0.83 CRBN (0.51) CRBNDDB1GSPT1KDM4EL3MBTL1
SCHEMBL26089304 0.83 CRBN (0.51) CRBNDDB1GSPT1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069731-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback